These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 37122433)

  • 1. Management of diabesity: Current concepts.
    Michaelidou M; Pappachan JM; Jeeyavudeen MS
    World J Diabetes; 2023 Apr; 14(4):396-411. PubMed ID: 37122433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabesity and antidiabetic drugs.
    Pappachan JM; Fernandez CJ; Chacko EC
    Mol Aspects Med; 2019 Apr; 66():3-12. PubMed ID: 30391234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical Management of Diabesity: Do We Have Realistic Targets?
    Pappachan JM; Viswanath AK
    Curr Diab Rep; 2017 Jan; 17(1):4. PubMed ID: 28101792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabesity and Dietary Interventions: Evaluating the Impact of Mediterranean Diet and Other Types of Diets on Obesity and Type 2 Diabetes Management.
    Pavlidou E; Papadopoulou SK; Fasoulas A; Papaliagkas V; Alexatou O; Chatzidimitriou M; Mentzelou M; Giaginis C
    Nutrients; 2023 Dec; 16(1):. PubMed ID: 38201865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-pharmacological Treatment Options in the Management of Diabetes Mellitus.
    Raveendran AV; Chacko EC; Pappachan JM
    Eur Endocrinol; 2018 Sep; 14(2):31-39. PubMed ID: 30349592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical Management of Diabesity.
    Chawla R; Jaggi S
    J Assoc Physicians India; 2019 Dec; 67(12):52-56. PubMed ID: 31801332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug treatments to restore vascular function and diabesity.
    Cardillo C
    Ann Pharm Fr; 2013 Jan; 71(1):27-33. PubMed ID: 23348853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 2021 Update on the Use of Liraglutide in the Modern Treatment of 'Diabesity': A Narrative Review.
    Tilinca MC; Tiuca RA; Burlacu A; Varga A
    Medicina (Kaunas); 2021 Jun; 57(7):. PubMed ID: 34209532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabesity: an overview of a rising epidemic.
    Farag YM; Gaballa MR
    Nephrol Dial Transplant; 2011 Jan; 26(1):28-35. PubMed ID: 21045078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic agents in the context of metabolic/bariatric surgery: expanding the scope and impact of diabetes drug discovery.
    Janero DR
    Expert Opin Drug Discov; 2014 Mar; 9(3):221-8. PubMed ID: 24397872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting endothelial metaflammation to counteract diabesity cardiovascular risk: Current and perspective therapeutic options.
    Potenza MA; Nacci C; De Salvia MA; Sgarra L; Collino M; Montagnani M
    Pharmacol Res; 2017 Jun; 120():226-241. PubMed ID: 28408314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with GLP-1 analogues and SGLT-2 inhibitors in the management of diabesity: the real world experience.
    Deol H; Lekkakou L; Viswanath AK; Pappachan JM
    Endocrine; 2017 Jan; 55(1):173-178. PubMed ID: 27696231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consensus on Medical Nutrition Therapy for Diabesity (CoMeND) in Adults: A South Asian Perspective.
    Kapoor N; Sahay R; Kalra S; Bajaj S; Dasgupta A; Shrestha D; Dhakal G; Tiwaskar M; Sahay M; Somasundaram N; Reddy R; Bhattacharya S; Reddy VB; Viswanathan V; Krishnan D; Baruah M; Das AK
    Diabetes Metab Syndr Obes; 2021; 14():1703-1728. PubMed ID: 33889005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical therapy for diabesity.
    Arroyo K; Kini SU; Harvey JE; Herron DM
    Mt Sinai J Med; 2010; 77(5):418-30. PubMed ID: 20960546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of 'Diabesity': Beyond Pharmacotherapy.
    Singh H; Venkatesan V
    Curr Drug Targets; 2018; 19(14):1672-1682. PubMed ID: 29929463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study design and recruitment for a prospective controlled study of diabesity: Taiwan Diabesity Study.
    Lee WJ; Chang YC; Almalki O; Chao SH; Lu CH; Chen CC; Huang YY; Lee YC; Hsu CC
    Asian J Surg; 2019 Jan; 42(1):244-250. PubMed ID: 29631874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From classical dualistic antagonism to hormone synergy: potential of overlapping action of glucagon, insulin and GLP-1 for the treatment of diabesity.
    Kistkins S; Moser O; Ankudovičs V; Blizņuks D; Mihailovs T; Lobanovs S; Sourij H; Pfeiffer AFH; Pīrāgs V
    Endocr Connect; 2024 May; 13(5):. PubMed ID: 38579770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social determinants of diabesity and its association with multimorbidity among older adults in India: a population-based cross-sectional study.
    Sinha A; Puri P; Pati S
    BMJ Open; 2022 Nov; 12(11):e061154. PubMed ID: 36424108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabesity and mood disorders: Multiple links through the microbiota-gut-brain axis.
    Farzi A; Hassan AM; Zenz G; Holzer P
    Mol Aspects Med; 2019 Apr; 66():80-93. PubMed ID: 30513310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.